{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T22:33:45Z","timestamp":1792276425023,"version":"4.4.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T00:00:00Z","timestamp":1593648000000},"content-version":"vor","delay-in-days":1462,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.kint.2016.02.031","type":"journal-article","created":{"date-parts":[[2016,5,8]],"date-time":"2016-05-08T08:58:41Z","timestamp":1462697921000},"page":"172-180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Impaired postprandial lipemic response in chronic kidney disease"],"prefix":"10.1016","volume":"90","author":[{"given":"Jeffrey M.","family":"Saland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Satlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanna","family":"Zalsos-Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Cremers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry N.","family":"Ginsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2016.02.031_bib1","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/ki.2010.311","article-title":"Dyslipidemia in children with chronic kidney disease","volume":"78","author":"Saland","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.02.031_bib2","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"issue":"suppl 3","key":"10.1016\/j.kint.2016.02.031_bib3","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1053\/ajkd.1998.v32.pm9820463","article-title":"Controlling the epidemic of cardiovascular disease in chronic renal disease: where do we start?","volume":"32","author":"Levey","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2016.02.031_bib4","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s00467-007-0467-5","article-title":"Lipoprotein metabolism in chronic renal insufficiency","volume":"22","author":"Saland","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2016.02.031_bib5","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1525-139X.2009.00661.x","article-title":"Causes of dysregulation of lipid metabolism in chronic renal failure","volume":"22","author":"Vaziri","year":"2009","journal-title":"Semin Dial"},{"key":"10.1016\/j.kint.2016.02.031_bib6","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJM198208053070601","article-title":"Increased lipoprotein-remnant formation in chronic renal failure","volume":"307","author":"Nestel","year":"1982","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2016.02.031_bib7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0021-9150(85)90032-2","article-title":"Retinyl ester retention in chronic renal failure: further evidence for a defect in chylomicron remnant metabolism","volume":"57","author":"Wilson","year":"1985","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.kint.2016.02.031_bib8","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1172\/JCI107334","article-title":"Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man","volume":"52","author":"Brunzell","year":"1973","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2016.02.031_bib9","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1093\/ndt\/gfq697","article-title":"Postprandial metabolic response to a fat- and carbohydrate-rich meal in patients with chronic kidney disease","volume":"26","author":"Miyamoto","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2016.02.031_bib10","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/ki.1992.411","article-title":"Severe defect in clearing postprandial chylomicron remnants in dialysis patients","volume":"42","author":"Weintraub","year":"1992","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.02.031_bib11","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.metabol.2005.01.028","article-title":"Insulin resistance and postprandial triglyceride levels in primary renal disease","volume":"54","author":"Charlesworth","year":"2005","journal-title":"Metabolism"},{"key":"10.1016\/j.kint.2016.02.031_bib12","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1194\/jlr.M011163","article-title":"Plasma apolipoprotein C-III metabolism in patients with chronic kidney disease","volume":"52","author":"Ooi","year":"2011","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.kint.2016.02.031_bib13","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1194\/jlr.P900003-JLR200","article-title":"Chronic kidney disease delays VLDL-apoB-100 particle catabolism: potential role of apolipoprotein C-III","volume":"50","author":"Chan","year":"2009","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.kint.2016.02.031_bib14","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1053\/j.ajkd.2014.10.005","article-title":"KDOQI US commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD","volume":"65","author":"Sarnak","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2016.02.031_bib15","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0005-2760(80)90016-8","article-title":"Quantitative determination of human apolipoprotein C-III by electroimmunoassay","volume":"617","author":"Curry","year":"1980","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.kint.2016.02.031_bib16","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1172\/JCI116066","article-title":"Mechanism of hypertriglyceridemia in\u00a0human apolipoprotein (apo) CIII transgenic mice: diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles","volume":"90","author":"Aalto-Setala","year":"1992","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2016.02.031_bib17","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/S0021-9258(19)42899-8","article-title":"A\u00a0new apoprotein of human plasma very low density lipoproteins","volume":"249","author":"Shelburne","year":"1974","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.kint.2016.02.031_bib18","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0022-2275(20)37573-8","article-title":"Lipoprotein lipase-enhanced binding of human triglyceride-rich lipoproteins to heparan sulfate: modulation by apolipoprotein E and apolipoprotein C","volume":"37","author":"van Barlingen","year":"1996","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.kint.2016.02.031_bib19","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1161\/01.RES.33.4.403","article-title":"Further observations on the activation and inhibition of lipoprotein lipase by apolipoproteins","volume":"33","author":"Krauss","year":"1973","journal-title":"Circ Res"},{"key":"10.1016\/j.kint.2016.02.031_bib20","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0022-2275(20)41415-4","article-title":"Inhibition of lipoprotein lipase activity by synthetic peptides of apolipoprotein C-III","volume":"33","author":"McConathy","year":"1992","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.kint.2016.02.031_bib21","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0006-291X(72)80149-9","article-title":"Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein","volume":"46","author":"Brown","year":"1972","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.kint.2016.02.031_bib22","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1126\/science.2167514","article-title":"Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice","volume":"249","author":"Ito","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.kint.2016.02.031_bib23","doi-asserted-by":"crossref","first-page":"23610","DOI":"10.1016\/S0021-9258(17)31559-4","article-title":"Targeted disruption of the apolipoprotein C-III gene in mice results in hypotriglyceridemia and protection from postprandial hypertriglyceridemia","volume":"269","author":"Maeda","year":"1994","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.kint.2016.02.031_bib24","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1161\/CIRCRESAHA.111.300367","article-title":"Antisense oligonucleotide inhibition of apolipoprotein C-III reduces plasma triglycerides in rodents, nonhuman primates, and humans","volume":"112","author":"Graham","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.kint.2016.02.031_bib25","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1172\/JCI112713","article-title":"Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI: evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by\u00a0lipoprotein lipase in\u00a0vivo","volume":"78","author":"Ginsberg","year":"1986","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2016.02.031_bib26","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1126\/science.1161524","article-title":"A\u00a0null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection","volume":"322","author":"Pollin","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.kint.2016.02.031_bib27","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1308027","article-title":"Loss-of-function mutations in APOC3 and risk of ischemic vascular disease","volume":"371","author":"Jorgensen","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2016.02.031_bib28","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1307095","article-title":"Loss-of-function mutations in APOC3, triglycerides, and coronary disease","volume":"371","author":"Crosby","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2016.02.031_bib29","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1056\/NEJMoa1400284","article-title":"Targeting APOC3 in the familial chylomicronemia syndrome","volume":"371","author":"Gaudet","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2016.02.031_bib30","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1172\/JCI200419992","article-title":"Foxo1 mediates insulin action on apoC-III and triglyceride metabolism","volume":"114","author":"Altomonte","year":"2004","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2016.02.031_bib31","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1016\/S0022-2275(20)39938-7","article-title":"Transcriptional regulation of the apoC-III gene by insulin in diabetic mice: correlation with changes in plasma triglyceride levels","volume":"35","author":"Chen","year":"1994","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.kint.2016.02.031_bib32","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1111\/j.1742-4658.2009.06914.x","article-title":"Novel genes in cell cycle control and lipid metabolism with dynamically regulated binding sites for sterol regulatory element-binding protein 1 and RNA polymerase II in HepG2 cells detected by chromatin immunoprecipitation with microarray detection","volume":"276","author":"Motallebipour","year":"2009","journal-title":"FEBS J"},{"key":"10.1016\/j.kint.2016.02.031_bib33","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1172\/JCI110532","article-title":"An abnormal triglyceride-rich lipoprotein containing excess sialylated apolipoprotein C-III","volume":"69","author":"Holdsworth","year":"1982","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2016.02.031_bib34","doi-asserted-by":"crossref","first-page":"F262","DOI":"10.1152\/ajprenal.00099.2005","article-title":"Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences","volume":"290","author":"Vaziri","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2016.02.031_bib35","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/ki.1997.129","article-title":"Down-regulation of VLDL receptor expression in chronic experimental renal failure","volume":"51","author":"Vaziri","year":"1997","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.02.031_bib36","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1038\/ki.1996.515","article-title":"Down-regulation of tissue lipoprotein lipase expression in experimental chronic renal failure","volume":"50","author":"Vaziri","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.02.031_bib37","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1046\/j.1523-1755.2002.00104.x","article-title":"Down-regulation of lipoprotein lipase and VLDL receptor in rats with focal glomerulosclerosis","volume":"61","author":"Sato","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.02.031_bib38","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s10157-011-0549-3","article-title":"Lipoprotein lipase deficiency in chronic kidney disease is accompanied by down-regulation of endothelial GPIHBP1 expression","volume":"16","author":"Vaziri","year":"2012","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.kint.2016.02.031_bib39","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1172\/JCI118657","article-title":"Abnormalities in hepatic lipase in chronic renal failure: role of excess parathyroid hormone","volume":"97","author":"Klin","year":"1996","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2016.02.031_bib40","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/j.1523-1755.2005.00166.x","article-title":"Down-regulation of hepatic LDL receptor-related protein (LRP) in chronic renal failure","volume":"67","author":"Kim","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.02.031_bib41","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cccn.2004.08.008","article-title":"Determination of apolipoprotein B-48 in serum by a sandwich ELISA","volume":"351","author":"Kinoshita","year":"2005","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.kint.2016.02.031_bib42","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD","volume":"20","author":"Schwartz","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.02.031_bib43","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1056\/NEJM199910073411506","article-title":"Nephropathy in patients with type 2 diabetes mellitus","volume":"341","author":"Ritz","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.kint.2016.02.031_bib44","first-page":"1","article-title":"Anthropometric reference data for children and adults: United States, 2003\u20132006","author":"McDowell","year":"2008","journal-title":"Natl Health Stat Rep"},{"key":"10.1016\/j.kint.2016.02.031_bib45","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.kint.2016.02.031_bib46","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4274\/jcrpe.v2i3.100","article-title":"Insulin resistance in obese children and adolescents: HOMA-IR cut-off levels in the prepubertal and pubertal periods","volume":"2","author":"Kurtoglu","year":"2010","journal-title":"J\u00a0Clin Res Pediatr Endocrinol"},{"key":"10.1016\/j.kint.2016.02.031_bib47","first-page":"21","article-title":"Insulin resistance and secretion indexes in healthy Italian children and adolescents: a multicentre study","volume":"80","author":"d'Annunzio","year":"2009","journal-title":"Acta Biomed"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253816300114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253816300114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T16:08:59Z","timestamp":1655741339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253816300114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0085253816300114"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2016.02.031","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impaired postprandial lipemic response in chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2016.02.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016, International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}